سعر سيتالوفار 40مجم 7 أقراص 2023

Citalofar 40mg 7 f.c.tab.: Citalopram 40 mg (Egyphar).

• SSRI antidepressant indicated for major depressive disorder and, depending on label, anxiety disorders (US citalopram labeling). Confirm Egyptian leaflet for approved indications.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Contraindicated with MAOIs (including linezolid/IV methylene blue) within 14 days; hypersensitivity to citalopram; concomitant pimozide where labeled (US labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults; monitor all patients. Risk of serotonin syndrome, QT prolongation (especially citalopram), hyponatremia, bleeding with NSAIDs/anticoagulants, activation of mania/hypomania, discontinuation syndrome (US SSRI labels).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Citalopram-specific: dose-dependent QT prolongation; US labeling restricts maximum dose (typically 40 mg/day; 20 mg/day in >60 years / hepatic impairment / poor CYP2C19 metabolizers / with cimetidine) — confirm Egyptian leaflet.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• MAOIs / other serotonergic drugsMajorSerotonin syndrome risk; MAOI combination contraindicated. Management: Do not combine with MAOIs; caution with other serotonergics.DailyMed (U.S. National Library of Medicine)

• SSRIs in pregnancy: possible neonatal adaptation syndrome and persistent pulmonary hypertension of the newborn risk signals; weigh risks/benefits (US PLLR-style labeling).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Citalopram: Inhibits serotonin reuptake; racemic citalopram.